Sintx Technologies Inc (SINT) Stock Price, Quote & News

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Am...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 839 3500

Website: www.sintx.com

Address:

1885 West 2100 South, Salt Lake City, United States

dogood Oct. 24 at 2:42 PM

$SINT will you run to $5

0 · Reply

StockGuy2424 Oct. 24 at 1:03 PM

$SINT dilution never ends

0 · Reply

MissionParabolica Oct. 24 at 2:25 AM

Make sure to keep eyes on ticker AWX for tomorrow.💎 Last time AWX woke up this ran over $5+. With how crazy current market is, AWX can potentially see double digit. Don't miss this opportunity bulls. AWX 🔹 Float super tight — Just at 1.5M 💎 🔹 Waste management + resort play. 🔹 Momentum traders all over this one⚡️ 🔹 When these tiny caps catch volume… anything can happen 💎 $YDKG $YYAI $SINT $BZAI ..1

0 · Reply

Boston7452 Oct. 23 at 4:26 PM

$SINT "SINTX has accelerated its transition from a diversified industrial-ceramics business to a pure-play medical device innovator" https://www.youtube.com/watch?v=BzAdXyPYKQo

4 · Reply

TheWatcher12 Oct. 23 at 4:08 PM

$SINT no revenue. $2 soon

1 · Reply

FastBull Oct. 23 at 1:33 PM

$SINT Send it to $1 where it belongs!

0 · Reply

Boston7452 Oct. 22 at 7:14 PM

$SINT hardcore dilution is due to those attacking the stock. This boils down to chicken v egg debate. Sonny created value throughout his tenure but that value was never allowed to be reflected in the stockprice. Thats why once they announce partnerships this will see massive increase in valuation. Billion dollar IP.

2 · Reply

SnoopyDog Oct. 22 at 7:01 PM

$SINT

1 · Reply

SnoopyDog Oct. 22 at 6:09 PM

$SINT the stock is stinky

1 · Reply

Boston7452 Oct. 22 at 6:05 PM

$SINT Has R&D partnerships in Ortho, Wound Care, PPE, & Oncology at the very least. When will they announce licensing/commercialization agreements?

1 · Reply

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Oct 14, 2025, 7:00 AM EDT - 10 days ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Sep 8, 2025, 7:54 AM EDT - 6 weeks ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:00 AM EDT - 6 weeks ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Aug 15, 2025, 7:00 AM EDT - 2 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 4, 2025, 7:00 AM EDT - 2 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Jun 24, 2025, 8:30 AM EDT - 4 months ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

May 22, 2025, 7:00 AM EDT - 5 months ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 15, 2025, 7:05 AM EDT - 5 months ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

Feb 26, 2025, 8:00 AM EST - 8 months ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 20, 2025, 6:15 AM EST - 8 months ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 19, 2025, 6:00 AM EST - 8 months ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Jun 18, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies to Explore Strategic Opportunities

Jun 12, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 6, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

May 23, 2024, 9:00 AM EDT - 1 year ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

Apr 29, 2024, 9:14 AM EDT - 1 year ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 3, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 1 year ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Feb 23, 2024, 7:50 AM EST - 1 year ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

GRI

Feb 21, 2024, 9:00 AM EST - 1 year ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 2, 2024, 2:33 PM EST - 1 year ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 1 year ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 30, 2024, 4:01 PM EST - 1 year ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 23, 2024, 9:00 AM EST - 1 year ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 4, 2024, 9:00 AM EST - 1 year ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT HSCS

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Aug 17, 2023, 9:00 AM EDT - 2 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Feb 14, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 2 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 10, 2023, 1:52 PM EST - 2 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 2 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 6, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Dec 21, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

Dec 19, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

Oct 26, 2022, 9:00 AM EDT - 3 years ago

SINTX TECHNOLOGIES AWARDED MULTI-YEAR DARPA CONTRACT TO DEVELOP CMCs AND HIGH TEMPERATURE COATINGS FOR TURBINE ENGINES

Oct 13, 2022, 8:30 AM EDT - 3 years ago

SINTX Technologies, Inc. Announces Subscriptions of Approximately $4.7 Million from its Rights Offering

Oct 11, 2022, 9:00 AM EDT - 3 years ago

SINTX TECHNOLOGIES RECEIVES PRODUCTION ORDER FOR AEROSPACE COMPONENTS

Oct 4, 2022, 11:05 AM EDT - 3 years ago

SINTX ANNOUNCES NEW ANTIBACTERIAL BIOMEDICAL PATENTS AND EXPANSION OF INTELLECTUAL PROPERTY PORTFOLIO

dogood Oct. 24 at 2:42 PM

$SINT will you run to $5

0 · Reply

StockGuy2424 Oct. 24 at 1:03 PM

$SINT dilution never ends

0 · Reply

MissionParabolica Oct. 24 at 2:25 AM

0 · Reply

Boston7452 Oct. 23 at 4:26 PM

$SINT "SINTX has accelerated its transition from a diversified industrial-ceramics business to a pure-play medical device innovator" https://www.youtube.com/watch?v=BzAdXyPYKQo

4 · Reply

TheWatcher12 Oct. 23 at 4:08 PM

$SINT no revenue. $2 soon

1 · Reply

FastBull Oct. 23 at 1:33 PM

$SINT Send it to $1 where it belongs!

0 · Reply

Boston7452 Oct. 22 at 7:14 PM

2 · Reply

SnoopyDog Oct. 22 at 7:01 PM

$SINT

1 · Reply

SnoopyDog Oct. 22 at 6:09 PM

$SINT the stock is stinky

1 · Reply

Boston7452 Oct. 22 at 6:05 PM

$SINT Has R&D partnerships in Ortho, Wound Care, PPE, & Oncology at the very least. When will they announce licensing/commercialization agreements?

1 · Reply

Boston7452 Oct. 22 at 5:24 PM

$SINT

1 · Reply

FastBull Oct. 22 at 3:48 PM

$SINT

0 · Reply

BillionerOfKing Oct. 22 at 3:31 PM

$SINT Current Stock Price: $3.26 No options data available.

0 · Reply

Rybod30 Oct. 22 at 2:45 PM

$SINT Whether this approaches ~$4 again or not, appears a long hold🤷‍♂️😬…

0 · Reply

EarlofLondon Oct. 22 at 1:42 PM

$BYND Halted up $SINT Come over when you finish with BYND $30 Billion FDA approval sector Many missed the news few days ago

0 · Reply

EarlofLondon Oct. 22 at 1:22 PM

$SINT So CEO bought yesterday doesn't mean anything for Shorters FDA approval means nothing for Shorters OK have fun Shorters One day our time will come

0 · Reply

RealSituation Oct. 22 at 1:01 PM

$SINT 🪫. 💩

0 · Reply

TheWatcher12 Oct. 22 at 12:38 PM

$SINT lower

0 · Reply

EarlofLondon Oct. 22 at 12:20 PM

$BENF When volume comes $SINT run will be 1000% time more than BYND Because of the potential in $4BILLION sector which only can be accessed by FDA approval, and that's what SINT has FDA approval Mcap $12M only on SINT 🇺🇸😳

0 · Reply

EarlofLondon Oct. 22 at 12:18 PM

$BYND When volume comes $SINT run will be 1000% time more than BYND Because of the potential in $4BILLION sector which only can be accessed by FDA approval, and that's what SINT has FDA approval Mcap $12M only on SINT 🇺🇸😳

1 · Reply

jcamp657 Oct. 22 at 11:34 AM

$SINT 🐕 💩

0 · Reply

OTC85 Oct. 22 at 10:01 AM

$SINT $BYND

0 · Reply

Market Cap	12.41M
Revenue (ttm)	2.89M
Net Income (ttm)	-11.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-381.31%
Debt to Equity Ratio	0.03

Volume	163,600
Avg Vol	1,079,506
Day's Range	N/A - N/A
Shares Out	3.59M
Stochastic %K	48%
Beta	0.83
Analysts	Sell
Price Target	$25.00